Canadian application, no grantCanada
Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
CA 2401086 A1 · Owner: Tovey, Michael Gerard · Inventors: Tovey, Michael Gerard
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Oromucosal administration of antagonists of cytokines associated with stimulation or enhancement of T helper 1 cell responses preferably for , example a Type 1-interferon antibody is disclosed for inhibition of , prevention of autoimmune diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 25, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 25, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 25, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 25, 2001
GrantedNo grant recorded
Term endedJanuary 25, 2021
Patent numberCA 2401086 A1
Classification (IPC)A61K39/39 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.